Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

Lifecore Biomedical (NASDAQ: LFCR) said it will participate at the 44th Annual J.P.

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR) said it will participate at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, January 12-15, 2026.

Company management, including Paul Josephs (chief executive officer) and Ryan Lake (chief financial officer), are scheduled to participate in 1-on-1 meetings during the conference.

Argus Dec 16 session

-2.16% close to close Open Argus

Details

News Market Reaction – LFCR

On Dec 16, the day this news came out, LFCR closed 2.16% below the previous close.

Data tracked by StockTitan Argus for the Dec 16 session.

Market Context

This announcement highlights Lifecore’s participation in the 44th J.P. Morgan Healthcare Conference ...

Analysis

This announcement highlights Lifecore’s participation in the 44th J.P. Morgan Healthcare Conference from January 12–15, 2026, continuing a pattern of active investor outreach following recent collaborations and commercial agreements. Investors may contextualize this with prior filings that include a Form S-3 for up to 20,456,637 resalable shares and disclosures of internal control weaknesses. Monitoring future updates from the conference and subsequent SEC filings will be important for assessing execution and capital structure developments.

Key Figures

Conference edition: 44th Annual Conference dates: January 12-15, 2026

Conference edition

44th Annual

J.P. Morgan Healthcare Conference

Conference dates

January 12-15, 2026

J.P. Morgan Healthcare Conference in San Francisco

Historical Context

5 past events · Latest: Nov 11

5 events

1. Nov 11

   Investor conferences

   24h Move

   +6.2%

   Participation in Jefferies and Stephens conferences with presentations and meetings.

2. Nov 06

   Earnings update

   24h Move

   -2.2%

   Q3 2025 results with revenue growth, better EBITDA, and guidance details.

3. Oct 30

   Earnings scheduling

   24h Move

   +1.3%

   Announcement of Q3 results date and related investor webcast details.

4. Oct 29

   New CDMO contract

   24h Move

   +2.3%

   New commercial manufacturing agreement and pre-clinical formulation deal.

5. Oct 28

   Collaboration deal

   24h Move

   +2.5%

   Collaboration with PolyPeptide for end-to-end peptide manufacturing in U.S.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

contract development and manufacturing organization, cdmo

2 terms

contract development and manufacturing organization technical

"Lifecore), a fully integrated contract development and manufacturing organization (“CDMO”)"

A contract development and manufacturing organization (CDMO) is a specialized service provider that helps other companies design, test, produce and package drugs or medical products on a hired basis. Think of it as an outsourced factory and R&D partner that lets a company scale production without building its own plants. Investors watch CDMO relationships because they affect a drug’s time-to-market, manufacturing costs, supply reliability and overall project risk, all of which influence future revenue and valuation.

cdmo technical

"fully integrated contract development and manufacturing organization (“CDMO”)"

A contract development and manufacturing organization (CDMO) is a company that provides specialized services to help develop and produce pharmaceutical products for other businesses. Think of it as a contract factory that takes a company's recipe and makes the product on their behalf. For investors, CDMOs are important because they support the growth of pharmaceutical companies and can be key partners in bringing new medicines to market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CHASKA, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 44^th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco, California.

Details regarding Lifecore’s participation are as follows:

• 44^th Annual J.P. Morgan Healthcare Conference
  Details: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings
  Conference Dates: January 12-15, 2026
  Location: San Francisco, California

About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com

Tim Brons (Media)
415-675-7402
tbrons@vidasp.com

Ryan D. Lake (CFO)
Lifecore Biomedical
952-368-6244
ryan.lake@lifecore.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Lifecore (LFCR) attend the 44th Annual J.P. Morgan Healthcare Conference?

Lifecore will participate January 12-15, 2026 in San Francisco.

Which Lifecore executives will attend the J.P. Morgan conference for LFCR?

Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, are scheduled to participate.

What type of meetings will Lifecore (LFCR) hold at the January 2026 J.P. Morgan conference?

The announcement states Lifecore management will participate in 1-on-1 meetings.

Is there a public presentation or webcast for Lifecore (LFCR) at the J.P. Morgan conference?

The announcement specifies 1-on-1 meetings and does not mention a public presentation or webcast.

Where is the 44th Annual J.P. Morgan Healthcare Conference taking place for LFCR attendees?

The conference is in San Francisco, California, January 12-15, 2026.

How can investors request a meeting with Lifecore (LFCR) at the J.P. Morgan conference?

The announcement lists management participation in 1-on-1 meetings but does not provide meeting request instructions.